Skip to main content

Liberty Health Sciences Inc (LHS-CN) Quote

Unchecking box will stop auto data updates
CSE Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 0.530
Day High 0.590
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Liberty Health Sciences Inc is committed to delivering pharmaceutical-grade cannabis to patients. The company produces pharmaceutical-grade marijuana. The company is based and operates in the United States and Canada. The company generated most of its revenue from medical cannabis.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Latest Press Releases

Consumer Trends Shift the Cannabis Market Spotlight on Extracts
PR Newswire Europe - Mon Jul 1, 8:01AM CDT
PR Newswire Europe - CMTX
Mon Jul 1, 8:01AM CDT
As the cannabis industry continues to mature, consumers are beginning to demand fresh, new products. Traditionally, most consumers smoked cannabis via joints or other paraphernalia. Now, while it still is the most popular method, the number of users simply smoking cannabis is quickly diminishing. Each year, reports have shown that more users are beginning to use cannabis alternative products such as edibles, concentrates, and extracts. The concentrates and extracts markets are gaining traction particularly quickly. For instance, when Colorado began its legal adult-use cannabis sales, flower dominated the marketplace. By the end of the first year, flower accounted for 67% of Colorado's overall cannabis sales, according to BDS Analytics. However, four years later, flower sales plummeted and have accounted for just 44% of total sales. During the same time span, the concentrates market closed the gap as its market share increased from 15% to 31%. Similarly, California witnessed its flower sales falter during the first four months of adult-use sales. California's flower sales fell from 43% in the beginning to 40%, while concentrates narrowly rose from 30% to 31%. Just like every other global industry, consumer trends change each year and people begin to demand for innovative products. Consumers within the cannabis market are now demanding more potent and cleaner alternatives to smoking the plant. Furthermore, according to data compiled by Ameri Research, the global legal marijuana market was valued at USD 14.3 Billion in 2016. By 2024, legal marijuana global sales are projected to reach USD 63.5 Billion while exhibiting a CAGR of 21.1% from 2017 to 2024. AREV Brands International Ltd. (CSE: AREV), Auxly Cannabis Group Inc. , Liberty Health Sciences Inc (CSE: LHS), Nightfood Holdings, Inc. , United Cannabis Corporation
Liberty Health Sciences Continues To Expand Its Line Of Top Brands; Introducing Papa's Herb™ï and Lemon and Grass
PR Newswire - Mon Jun 10, 5:30AM CDT
PR Newswire - CMTX
Mon Jun 10, 5:30AM CDT
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company"), a provider of high quality cannabis, today announced that it is continuing to expand its product offerings by introducing two additional top brands: Papa's Herb(TM)ï ( and Lemon and Grass, subject to Florida Department of Health approval.
Liberty Health Sciences To Introduce Zentient As New House Brand Along With All-Natural Line of Pretty Pistil Products
PR Newswire - Thu Jun 6, 5:53PM CDT
PR Newswire - CMTX
Thu Jun 6, 5:53PM CDT
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company"), a provider of high quality cannabis, today announced that it will be introducing Zentient to all of its dispensaries as its new house brand of products along with a Pretty Pistil, subject to the Florida Department of Health approval. Pretty Pistil will be replacing all of Liberty's Solei branded products.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.510 +13.73% increase
on 07/15/19
Period Open:0.600
Price movement based on the high, low and last over the given period.
0.670 -13.43% decrease
on 07/02/19
-0.020 (-3.33%) decrease
since 06/17/19
3-Month 0.510 +13.73% increase
on 07/15/19
Period Open:0.850
Price movement based on the high, low and last over the given period.
0.950 -38.95% decrease
on 04/23/19
-0.270 (-31.76%) decrease
since 04/17/19
52-Week 0.510 +13.73% increase
on 07/15/19
Period Open:0.840
Price movement based on the high, low and last over the given period.
1.630 -64.42% decrease
on 10/01/18
-0.260 (-30.95%) decrease
since 07/17/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).